Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Imipramine MeSH Descriptor Data 2025


MeSH Heading
Imipramine
Tree Number(s)
D03.633.300.240.485
Unique ID
D007099
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D007099
Scope Note
The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
Entry Term(s)
4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2)
Imidobenzyle
Imipramine Hydrochloride
Imipramine Monohydrochloride
Imipramine Pamoate
Imizin
Janimine
Melipramine
Norchlorimipramine
Pryleugan
Tofranil
Pharm Action
Antidepressive Agents, Tricyclic
Adrenergic Uptake Inhibitors
Registry Numbers
OGG85SX4E4
0
BKE5Q1J60U
MC34P30298
Related Numbers
113-52-0
50-49-7
BKE5Q1J60U
MC34P30298
CAS Type 1 Name
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-
NLM Classification #
QV 77.5
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2018/07/02
Imipramine Preferred
Janimine Narrower
Melipramine Narrower
Imipramine Hydrochloride Narrower
Tofranil Narrower
Pryleugan Narrower
Imizin Narrower
Imipramine Pamoate Narrower
page delivered in 0.135s